Jefferies Financial Group Inc. Purchases 41,300 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Jefferies Financial Group Inc. raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 98.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 83,100 shares of the company’s stock after acquiring an additional 41,300 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Henry Schein were worth $5,751,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Olstein Capital Management L.P. grew its holdings in Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares during the period. Private Management Group Inc. grew its holdings in Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock valued at $24,256,000 after purchasing an additional 18,882 shares during the period. Equitable Trust Co. bought a new position in Henry Schein during the fourth quarter valued at $417,000. Savant Capital LLC grew its holdings in Henry Schein by 43.9% during the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock valued at $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock valued at $1,113,000 after purchasing an additional 3,650 shares during the period. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HSIC. Wells Fargo & Company cut their price target on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. StockNews.com cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Piper Sandler reduced their price target on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Finally, Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Price Performance

NASDAQ:HSIC opened at $68.68 on Monday. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 28.26, a P/E/G ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The stock has a fifty day moving average of $67.59 and a 200 day moving average of $71.46. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the company earned $1.10 earnings per share. On average, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insiders Place Their Bets

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.